These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9275421)

  • 21. Three-dimensional power Doppler study of endometrial and subendometrial microvascularization in women with intrauterine device-induced menorrhagia.
    El-Mazny A; Abou-Salem N; Elshenoufy H
    Fertil Steril; 2013 Jun; 99(7):1912-5. PubMed ID: 23465819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term reversible contraception. Twelve years of experience with the TCu380A and TCu220C.
    Contraception; 1997 Dec; 56(6):341-52. PubMed ID: 9494767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparative study of the levonorgestrel-releasing intrauterine system Mirena versus the Copper T380A intrauterine device during lactation: breast-feeding performance, infant growth and infant development.
    Shaamash AH; Sayed GH; Hussien MM; Shaaban MM
    Contraception; 2005 Nov; 72(5):346-51. PubMed ID: 16246660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Endometrial changes in the presence of a progesterone-releasing IUD. Cytological evaluation].
    Cinel A; Insacco E; Minucci D
    Minerva Ginecol; 1988 Jan; 40(1):1-8. PubMed ID: 3287230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of copper-containing intrauterine contraceptive devices (IUCD) on growth of endometrial and cervical cells.
    Amin NS; Al-janabi NY; Banna HB; Al-tai S; Al-kateeb A; Kubba K; Al-nasiri N
    Med Sci Res; 1989 May 1-15; 17(9):433-4. PubMed ID: 12283436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Statement on intrauterine devices (IUDs).
    International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP
    IPPF Med Bull; 1987 Dec; 21(6):3-5. PubMed ID: 12268853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive overview of intrauterine contraceptive device (IUCD).
    Nnatu S
    J Obstet Gynaecol East Cent Africa; 1983 Sep; 2(3):91-6. PubMed ID: 12340192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigation of the release behavior of cupric ion for three types of Cu-IUDs and indomethacin for medicated Cu-IUD in simulated uterine fluid.
    Jinying L; Ying L; Xuan G; Yanli G; Jianping L
    Contraception; 2008 Apr; 77(4):299-302. PubMed ID: 18342655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in effect of copper and ProgestasertR IUDS on fibrinolytic activity of the endometrium in the rabbit.
    Liedholm P; Sjöberg NO
    Contraception; 1979 May; 19(5):443-8. PubMed ID: 467053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intrauterine devices. The optimal long-term contraceptive method?
    Fortney JA; Feldblum PJ; Raymond EG
    J Reprod Med; 1999 Mar; 44(3):269-74. PubMed ID: 10202746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prophylactic use of prostaglandin synthesis inhibitors in connection with IUD insertion].
    Jensen HH; Blaabjerg J; Lyndrup J
    Ugeskr Laeger; 1998 Nov; 160(48):6958-61. PubMed ID: 9846090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preventing copper intrauterine device removals due to side effects among first-time users: randomized trial to study the effect of prophylactic ibuprofen.
    Hubacher D; Reyes V; Lillo S; Pierre-Louis B; Zepeda A; Chen PL; Croxatto H
    Hum Reprod; 2006 Jun; 21(6):1467-72. PubMed ID: 16484309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of leukaemia inhibitory factor (LIF) during the window of implantation in copper T380A intrauterine device users.
    Güney M; Oral B; Karahan N; Mungan T
    Eur J Contracept Reprod Health Care; 2007 Sep; 12(3):212-9. PubMed ID: 17763259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IUD-induced uterine bleeding.
    El-badrawi HH; Hafez ES
    Contracept Deliv Syst; 1980 Oct; 1(4):303-18. PubMed ID: 12262133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Artificial insemination. Role of endometrial thickness and pattern, of vascular impedance of the spiral and uterine arteries, and of the dominant follicle.
    Tsai HD; Chang CC; Hsieh YY; Lee CC; Lo HY
    J Reprod Med; 2000 Mar; 45(3):195-200. PubMed ID: 10756496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of the levonorgestrel intrauterine system on uterine artery blood flow 1 year after insertion.
    Haberal A; Kayikcioglu F; Gunes M; Kaplan M; Ozdegirmenci O
    Ultrasound Obstet Gynecol; 2006 Mar; 27(3):316-9. PubMed ID: 16450358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of menstrual blood loss in Brazilian users of the frameless copper-releasing IUD with copper surface area of 330 mm2 and the frameless levonorgestrel-releasing intrauterine system.
    Andrade AT; Souza JP; Andrade GN; Rowe PJ; Wildemeersch D
    Contraception; 2004 Aug; 70(2):173-7. PubMed ID: 15288225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cellular changes in the glandular epithelium of the endometrial and endocervical mucosa of women using the IUD (CU 7 device)].
    Zanetta G; Confalonieri C
    Ann Ostet Ginecol Med Perinat; 1979; 100(6):442-7. PubMed ID: 554521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The influence of immediate postpartum insertion of GyneFix PP-intrauterine devices on puerperal period].
    Pan J; Li Y; Xie L
    Zhonghua Fu Chan Ke Za Zhi; 1998 Jan; 33(1):40-2. PubMed ID: 10682458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The use of three-dimensional ultrasound imaging in detecting the type and location of intrauterine contraceptive device].
    Zhang S; Ying W; Xu J; Yang M; Xu K; Luo Q
    Zhonghua Yi Xue Za Zhi; 2002 Apr; 82(7):459-61. PubMed ID: 12133515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.